药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Papaverine
Blinatumomab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Blinatumomab.
Papaverine
Siltuximab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Siltuximab.
Papaverine
Vedolizumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Vedolizumab.
Papaverine
Secukinumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Secukinumab.
Papaverine
Fluprednidene
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Fluprednidene.
Papaverine
Obinutuzumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Obinutuzumab.
Papaverine
Pomalidomide
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Pomalidomide.
Papaverine
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Dimethyl fumarate.
Papaverine
Fluticasone furoate
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Fluticasone furoate.
Papaverine
Certolizumab pegol
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Certolizumab pegol.
Papaverine
Ponatinib
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Ponatinib.
Papaverine
Carfilzomib
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Carfilzomib.
Papaverine
Teriflunomide
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Teriflunomide.
Papaverine
Belimumab
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Belimumab.
Papaverine
Ruxolitinib
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Ruxolitinib.
Papaverine
Eribulin
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Eribulin.
Papaverine
Brentuximab vedotin
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Brentuximab vedotin.
Papaverine
Wortmannin
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Wortmannin.
Papaverine
Pralatrexate
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Pralatrexate.
Papaverine
Cabazitaxel
The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Cabazitaxel.